top of page


palavicinij
Admin
More actions
Profile
Join date: Sep 10, 2023
Posts (33)
Apr 21, 2026 ∙ 3 min
UT San Antonio team studies circadian disruption’s role in Alzheimer’s disease
Shared By: Claire Kowalick Alzheimer’s is a highly heritable disease with about 60% of the risk coming from a person’s genes. The other 40% of the risk remains less well-studied and may, in part, come from environmental stressors. The University of Texas at San Antonio was recently awarded a highly competitive Alzheimer’s Association research grant to investigate the gene-environment interaction and how it may contribute to an increased risk for Alzheimer’s disease. The grant will begin in...
1
0
Apr 10, 2026 ∙ 1 min
☕Palavicini Lab Shares ALZ‑Funded Research at Walk to End Alzheimer’s Corporate Breakfast💜
At the recent San Antonio Walk to End Alzheimer’s Corporate Breakfast, hosted by HealthTexas, Juan Pablo Palavicini, PhD, was invited to give a brief overview of the lab’s Alzheimer’s Association‑funded projects and ongoing clinical research efforts. Surrounded by local corporate and community leaders, the event highlighted the strong regional commitment to advancing brain health, expanding clinical trial participation, and supporting innovative, locally driven Alzheimer’s research. Juan...
3
0
Apr 2, 2026 ∙ 1 min
🧑🔬Eduardo Selected to Present at Cellular & Integrative Physiology Research Day 2026📊
Third‑year PhD student Eduardo Gutierrez was selected to give a research talk at the UT Health San Antonio Cellular & Integrative Physiology Research Day, held April 2, 2026 on the Long Campus. His presentation, “PLCG2‑Dependent Microglial TLR4 Innate Immune Responses: In Vivo and In Vitro Studies in PLCG2‑Deficient Mice,” showcased collaborative work between the Hopp and the Palavicini labs.
4
0
bottom of page